Buscar
Mostrando ítems 1-10 de 47
Primary sclerosing cholangitis and inflammatory bowel disease: Intestine---liver interrelation
(Elsevier, 2019)
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered a distinct clinical entity. This association involves genetic abnormalities, epidemiological factors (more ...
Biomarcadores en enfermedad inflamatoria intestinal: ¿sabe cómo utilizarlos?
(Sociedad Médica de Santiago, 2020)
Biomarkers in inflammatory bowel disease are an essential tool in clinical practice. They allow a non-invasive evaluation of patients and thus guide decision-making at different stages of the disease, including diagnostic ...
Riesgo de infección en pacientes con enfermedades inmunológicas y oncológicas tratados con biológicos: revisión panorámica
(Sociedad Médica de Santiago, Chile, 2020)
Biological medications are effective for the treatment of cancer and inflammatory diseases. The aim of this review is to summarize the available evidence in systematic reviews or meta-analyses about the risk of infection ...
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
(2010)
Background: ST2 has been proposed to be a regulator of inflammation and Th1/Th2 balance. ST2L is the IL-33 membrane receptor and belongs to the IL-1R family. The soluble variant, ST2s, is identical to the extracellular ...
Inflammatory bowel diseases: An immunological approach Enfermedad inflamatoria intestinal: Una mirada inmunológica
(2008)
Inflammatory bowel diseases (IBD) are inflammatory diseases with a multifactorial component that involve the intestinal tract. The two relevant IBD syndromes are Crohn's disease (CD) and ulcerative colitis (UC). One factor ...
Glucocorticosteroid therapy in inflammatory bowel diseases: from clinical practice to molecular biology
(Baishideng Publishing Group, 2017)
Inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn's disease, are chronic pathologies associated with a deregulated immune response in the intestinal mucosa, and they are triggered by environmental ...
Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?
(Baishideng Publishing Group, 2021)
Compelling evidence supports the crucial role of the receptor for advanced
glycation end-products (RAGE) axis activation in many clinical entities. Since the
beginning of the coronavirus disease 2019 pandemic, there is ...
Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis
(2009)
Crohn's disease (CD) and ulcerative colitis (UC) belong to the group of inflammatory bowel diseases (IBD), with complex ethiopathogenic factors that include an unbalanced immune and inflammatory response to commensal and ...
Biomarkers in inflammatory bowel disease
(Sociedad Medica de Santiago, 2020)
Oxidative stress, prooxidants and Crohn disease Estrés oxidativo, prooxidantes y enfermedad de Crohn
(2006)
The frequency of Crohn disease shows a significant increase in the last century. Affected patients show a misbalance between production of free radicals and anti oxidant defenses. Thus, one of the increasingly accepted ...